172 related articles for article (PubMed ID: 28689747)
1. Hypoxia inhibits growth, proliferation, and increases response to chemotherapy in retinoblastoma cells.
Yang Q; Tripathy A; Yu W; Eberhart CG; Asnaghi L
Exp Eye Res; 2017 Sep; 162():48-61. PubMed ID: 28689747
[TBL] [Abstract][Full Text] [Related]
2. Targeting hypoxia, a novel treatment for advanced retinoblastoma.
Boutrid H; Jockovich ME; Murray TG; Piña Y; Feuer WJ; Lampidis TJ; Cebulla CM
Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):2799-805. PubMed ID: 18326690
[TBL] [Abstract][Full Text] [Related]
3. Effect of curcumin on miRNA expression in human Y79 retinoblastoma cells.
Sreenivasan S; Thirumalai K; Danda R; Krishnakumar S
Curr Eye Res; 2012 May; 37(5):421-8. PubMed ID: 22510010
[TBL] [Abstract][Full Text] [Related]
4. Microarray analysis and biochemical correlations of oxidative stress responsive genes in retinoblastoma.
Vandhana S; Lakshmi TS; Indra D; Deepa PR; Krishnakumar S
Curr Eye Res; 2012 Sep; 37(9):830-41. PubMed ID: 22668346
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of sodium iodide symporter (NIS) protein expression by an innate immunity component: Promising potential for targeting radiosensitive retinoblastoma.
Samuel J; Singh N; Kanwar JR; Krishnakumar S; Kanwar RK
Exp Eye Res; 2015 Oct; 139():108-14. PubMed ID: 26213306
[TBL] [Abstract][Full Text] [Related]
6. Different transcriptome profiles between human retinoblastoma Y79 cells and an etoposide-resistant subline reveal a chemoresistance mechanism.
Song WP; Zheng S; Yao HJ; Zhou XF; Li R; Zhang CY; Zhao JY; Wang LW; Shao RG; Li L
BMC Ophthalmol; 2020 Mar; 20(1):92. PubMed ID: 32143590
[TBL] [Abstract][Full Text] [Related]
7. Targeting Notch signaling as a novel therapy for retinoblastoma.
Asnaghi L; Tripathy A; Yang Q; Kaur H; Hanaford A; Yu W; Eberhart CG
Oncotarget; 2016 Oct; 7(43):70028-70044. PubMed ID: 27661116
[TBL] [Abstract][Full Text] [Related]
8. Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells.
Dalgard CL; Gonzalez M; deNiro JE; O'Brien JM
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4542-51. PubMed ID: 19443717
[TBL] [Abstract][Full Text] [Related]
9. Pharmaceutically inhibiting polo-like kinase 1 exerts a broad anti-tumour activity in retinoblastoma cell lines.
Schwermer M; Dreesmann S; Eggert A; Althoff K; Steenpass L; Schramm A; Schulte JH; Temming P
Clin Exp Ophthalmol; 2017 Apr; 45(3):288-296. PubMed ID: 27647547
[TBL] [Abstract][Full Text] [Related]
10. L1 increases adhesion-mediated proliferation and chemoresistance of retinoblastoma.
Jo DH; Lee K; Kim JH; Jun HO; Kim Y; Cho YL; Yu YS; Min JK; Kim JH
Oncotarget; 2017 Feb; 8(9):15441-15452. PubMed ID: 28061460
[TBL] [Abstract][Full Text] [Related]
11. The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro.
Poulaki V; Mitsiades CS; Kotoula V; Negri J; McMillin D; Miller JW; Mitsiades N
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4706-19. PubMed ID: 17898295
[TBL] [Abstract][Full Text] [Related]
12. Artesunate exerts specific cytotoxicity in retinoblastoma cells via CD71.
Zhao F; Wang H; Kunda P; Chen X; Liu QL; Liu T
Oncol Rep; 2013 Sep; 30(3):1473-82. PubMed ID: 23818062
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin, a mTOR inhibitor, induced growth inhibition in retinoblastoma Y79 cell via down-regulation of Bmi-1.
Wang YD; Su YJ; Li JY; Yao XC; Liang GJ
Int J Clin Exp Pathol; 2015; 8(5):5182-8. PubMed ID: 26191215
[TBL] [Abstract][Full Text] [Related]
14. TRIM59 Promotes Retinoblastoma Progression by Activating the p38-MAPK Signaling Pathway.
Wu C; Shang XQ; You ZP; Jin QF; Zhang YL; Zhou Y; Zhang YZ; Shi K
Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):2. PubMed ID: 32744597
[TBL] [Abstract][Full Text] [Related]
15. Effects of lentivirus-mediated astrocyte elevated gene-1 overexpression on proliferation and apoptosis of human retinoblastoma cells.
Bai H; Chang Y; Li B; Mao Y; Jonas JB
Acta Ophthalmol; 2019 May; 97(3):e397-e402. PubMed ID: 30694025
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of hypoxia-inducible factor-1 alpha reduces proliferation, induces apoptosis and attenuates the aggressive phenotype of retinoblastoma WERI-Rb-1 cells under hypoxic conditions.
Xia T; Cheng H; Zhu Y
Ann Clin Lab Sci; 2014; 44(2):134-44. PubMed ID: 24795051
[TBL] [Abstract][Full Text] [Related]
17. JQ1, a selective inhibitor of BRD4, suppresses retinoblastoma cell growth by inducing cell cycle arrest and apoptosis.
Zhang Y; Duan S; Jang A; Mao L; Liu X; Huang G
Exp Eye Res; 2021 Jan; 202():108304. PubMed ID: 33080301
[TBL] [Abstract][Full Text] [Related]
18. Lentiviral vector-mediated PAX6 overexpression promotes growth and inhibits apoptosis of human retinoblastoma cells.
Li L; Li B; Zhang H; Bai S; Wang Y; Zhao B; Jonas JB
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8393-400. PubMed ID: 21948554
[TBL] [Abstract][Full Text] [Related]
19. Basic fibroblast growth factor impact on retinoblastoma progression and survival.
Cebulla CM; Jockovich ME; Piña Y; Boutrid H; Alegret A; Kulak A; Hackam AS; Bhattacharya SK; Feuer WJ; Murray TG
Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5215-21. PubMed ID: 18614803
[TBL] [Abstract][Full Text] [Related]
20. Topotecan combination chemotherapy in two new rodent models of retinoblastoma.
Laurie NA; Gray JK; Zhang J; Leggas M; Relling M; Egorin M; Stewart C; Dyer MA
Clin Cancer Res; 2005 Oct; 11(20):7569-78. PubMed ID: 16243833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]